Xiromed debuts generic Rozerem

Xiromed is introducing Ramelteon Tablets, 8 mg, which is the generic of Takeda's Rozerem. 

The medication is used for the treatment of insomnia characterized by difficulty with sleep onset.

[Read more: Xiromed unveils generic Extina] 

Xiromed’s product will be available in 30-count and 100-count bottles.      

“Xiromed continues to expand its portfolio of generic pharmaceutical products with the launch of Ramelteon Tablets," said Rob Spina, CEO of Xiromed.

Spina added, "We remain focused on providing affordable and quality generic options for patients in the U.S. as our business continues to grow and expand.” 

[Read more: Xiromed launches generic Prilosec]

Annual sales for Rozerem and its generics for the 12-month period ending in July, 2023 were $21.4 million, per IQVIA.